rs771466122
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM2PP3_ModeratePP5_Very_Strong
The NM_025207.5(FLAD1):c.1588C>T(p.Arg530Cys) variant causes a missense change. The variant allele was found at a frequency of 0.0000242 in 1,614,000 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R530H) has been classified as Uncertain significance.
Frequency
Consequence
NM_025207.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FLAD1 | NM_025207.5 | c.1588C>T | p.Arg530Cys | missense_variant | 6/7 | ENST00000292180.8 | NP_079483.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FLAD1 | ENST00000292180.8 | c.1588C>T | p.Arg530Cys | missense_variant | 6/7 | 1 | NM_025207.5 | ENSP00000292180.3 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251490Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135920
GnomAD4 exome AF: 0.0000219 AC: 32AN: 1461894Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 727248
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74314
ClinVar
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 08, 2017 | The R530C variant in the FLAD1 gene has previously been reported in two individuals with adult onset riboflavin responsive multiple acyl-CoA dehydrogenase deficiency who were compound heterozygous for frameshift variants in FLAD1 (Olsen et al., 2016). Functional analysis of R530C found that is is associated with higher sensitivity to proteolytic degradation and significantly reduced catalytic activity compared to wild-type (Olsen et al., 2016). The R530C variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The R530C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved across species, and in silico analysis predicts this variant is probably damaging to the protein structure/function. In summary, we interpret R530C to be a pathogenic variant. - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Feb 27, 2023 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 530 of the FLAD1 protein (p.Arg530Cys). This variant is present in population databases (rs771466122, gnomAD 0.005%). This missense change has been observed in individual(s) with FLAD1-related conditions (PMID: 27259049, 31392824). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 224729). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be disruptive. Experimental studies have shown that this missense change affects FLAD1 function (PMID: 27259049). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Multiple acyl-CoA dehydrogenase deficiency Pathogenic:1
Pathogenic, criteria provided, single submitter | research | Research Unit for Molecular Medicine, Department for Clinical Medicine, Aarhus University | Mar 14, 2016 | - - |
FLAD1-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | Feb 21, 2023 | The FLAD1 c.1588C>T variant is predicted to result in the amino acid substitution p.Arg530Cys. This variant was reported in at least 3 individuals with multiple acyl-CoA dehydrogenase deficiency and multiple respiratory-chain deficiency (Olsen et al. 2016. PubMed ID: 27259049; Auranen et al. 2017. PubMed ID: 28433476; Muru et al. 2019. PubMed ID: 31392824). Functional studies suggest that the p.Arg530Cys substitution impacts the normal FLAD1protein function (Olsen et al. 2016. PubMed ID: 27259049). This variant is reported in 0.0050% of alleles in individuals of East Asian descent in gnomAD (http://gnomad.broadinstitute.org/variant/1-154965222-C-T). This variant is interpreted as likely pathogenic. - |
Myopathy with abnormal lipid metabolism Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 10, 2019 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at